Gratus Capital’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
$6.31M Buy
44,186
+12,518
+40% +$1.79M 0.25% 90
2024
Q1
$4.07M Hold
31,668
0.19% 98
2023
Q4
$3.28M Sell
31,668
-150
-0.5% -$15.5K 0.18% 97
2023
Q3
$2.89M Hold
31,818
0.2% 89
2023
Q2
$2.57M Hold
31,818
0.18% 94
2023
Q1
$2.53M Sell
31,818
-2,376
-7% -$189K 0.19% 84
2022
Q4
$2.31M Hold
34,194
0.19% 85
2022
Q3
$1.7M Sell
34,194
-778
-2% -$38.7K 0.18% 92
2022
Q2
$1.95M Sell
34,972
-450
-1% -$25.1K 0.22% 82
2022
Q1
$1.97M Sell
35,422
-1,576
-4% -$87.5K 0.19% 85
2021
Q4
$2.07M Buy
36,998
+656
+2% +$36.7K 0.19% 84
2021
Q3
$1.75M Buy
36,342
+1,412
+4% +$67.8K 0.19% 84
2021
Q2
$1.46M Sell
34,930
-16,190
-32% -$678K 0.16% 90
2021
Q1
$1.72M Sell
51,120
-3,274
-6% -$110K 0.21% 98
2020
Q4
$1.9M Buy
54,394
+114
+0.2% +$3.98K 0.25% 85
2020
Q3
$1.88M Sell
54,280
-810
-1% -$28.1K 0.29% 80
2020
Q2
$1.8M Sell
55,090
-1,262
-2% -$41.3K 0.3% 79
2020
Q1
$1.7M Sell
56,352
-1,138
-2% -$34.3K 0.32% 76
2019
Q4
$1.66M Sell
57,490
-2,250
-4% -$65.1K 0.25% 95
2019
Q3
$1.54M Sell
59,740
-700
-1% -$18.1K 0.25% 98
2019
Q2
$1.54M Buy
60,440
+1,160
+2% +$29.6K 0.25% 96
2019
Q1
$1.55M Buy
59,280
+180
+0.3% +$4.71K 0.26% 94
2018
Q4
$1.36M Buy
59,100
+200
+0.3% +$4.61K 0.28% 94
2018
Q3
$1.39M Sell
58,900
-800
-1% -$18.9K 0.19% 91
2018
Q2
$1.38M Sell
59,700
-2,300
-4% -$53.1K 0.2% 87
2018
Q1
$1.53M Hold
62,000
0.22% 88
2017
Q4
$1.66M Hold
62,000
0.22% 90
2017
Q3
$1.49M Hold
62,000
0.21% 91
2017
Q2
$1.33M Hold
62,000
0.19% 95
2017
Q1
$1.06M Buy
62,000
+20,216
+48% +$347K 0.15% 103
2016
Q4
$749K Sell
41,784
-1,272
-3% -$22.8K 0.11% 113
2016
Q3
$895K Buy
43,056
+1,284
+3% +$26.7K 0.13% 111
2016
Q2
$1.12M Buy
+41,772
New +$1.12M 0.17% 101